Literature DB >> 14732224

Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro.

Joong Sup Shim1, Hyi-Seung Lee, Jongheon Shin, Ho Jeong Kwon.   

Abstract

Psammaplin A (PsA) is a phenolic natural product isolated from a marine sponge, which showed a potent cytotoxicity against several cancer cell lines. In present study, PsA was found to inhibit mammalian aminopeptidase N (APN) that plays a key role in tumor cell invasion and angiogenesis. PsA inhibited the APN activity with an IC50 of 18 microM in a non-competitive manner. Moreover, PsA potently inhibited the proliferation of several cancer and endothelial cells. Interestingly, the anti-proliferative effect of PsA was dependent on the cellular amount of APN expression. Finally, PsA suppressed the invasion and tube formation of endothelial cells stimulated by basic fibroblast growth factor. These data demonstrate that PsA is a new inhibitor of APN and can be developed as a novel anti-angiogenic agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732224     DOI: 10.1016/j.canlet.2003.08.036

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

Review 1.  The marine bromotyrosine derivatives.

Authors:  Jiangnan Peng; Jing Li; Mark T Hamann
Journal:  Alkaloids Chem Biol       Date:  2005

2.  Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1.

Authors:  Emily Berry; Jennifer L Hardt; Jon Clardy; John R Lurain; J Julie Kim
Journal:  Gynecol Oncol       Date:  2008-11-28       Impact factor: 5.482

3.  Identification of a novel small molecule HIF-1alpha translation inhibitor.

Authors:  Takuhito Narita; Shaoman Yin; Christine F Gelin; Carlos S Moreno; Manuel Yepes; K C Nicolaou; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

4.  Psammaplin A inhibits hepatitis C virus NS3 helicase.

Authors:  Kazi Abdus Salam; Atsushi Furuta; Naohiro Noda; Satoshi Tsuneda; Yuji Sekiguchi; Atsuya Yamashita; Kohji Moriishi; Masamichi Nakakoshi; Masayoshi Tsubuki; Hidenori Tani; Junichi Tanaka; Nobuyoshi Akimitsu
Journal:  J Nat Med       Date:  2013-01-29       Impact factor: 2.343

5.  Metalloproteinase inhibitors: status and scope from marine organisms.

Authors:  Noel Vinay Thomas; Se-Kwon Kim
Journal:  Biochem Res Int       Date:  2010-12-09

6.  In vitro evaluation of natural marine sponge collagen as a scaffold for bone tissue engineering.

Authors:  Zhen Lin; Kellie L Solomon; Xiaoling Zhang; Nathan J Pavlos; Tamara Abel; Craig Willers; Kerong Dai; Jiake Xu; Qiujian Zheng; Minghao Zheng
Journal:  Int J Biol Sci       Date:  2011-08-07       Impact factor: 6.580

Review 7.  Anticancer Activity of Natural Compounds from Plant and Marine Environment.

Authors:  Anna Lichota; Krzysztof Gwozdzinski
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

8.  Synthesis of the marine bromotyrosine psammaplin F and crystal structure of a psammaplin A analogue.

Authors:  Qianjiao Yang; Dan Liu; Deyang Sun; Sen Yang; Guodong Hu; Zuti Wu; Linxiang Zhao
Journal:  Molecules       Date:  2010-12-02       Impact factor: 4.411

Review 9.  Marine-derived angiogenesis inhibitors for cancer therapy.

Authors:  Ying-Qing Wang; Ze-Hong Miao
Journal:  Mar Drugs       Date:  2013-03-15       Impact factor: 5.118

Review 10.  The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting.

Authors:  Luciano Pirola; Oskar Ciesielski; Aneta Balcerczyk
Journal:  Cancers (Basel)       Date:  2018-08-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.